The global Preclinical Pharmacokinetics Services market was valued at US$ 782 million in 2025 and is anticipated to reach US$ 1123 million by 2032, at a CAGR of 5.3% from 2026 to 2032.

Preclinical Pharmacokinetics Services Market

Preclinical Pharmacokinetics Services refer to professional technical services tailored for drug R&D, focusing on studying the absorption, distribution, metabolism, and excretion (ADME) processes of candidate drugs in preclinical experimental systems (in vitro, in vivo, ex vivo) as well as the dynamic changes of drug concentration in biological matrices over time; relying on GLP-compliant laboratories, specialized detection platforms (e.g., LC-MS/MS) and standardized experimental protocols, these services conduct tests on experimental animals (rats, mice, dogs, monkeys, etc.) or in vitro models (liver microsomes, Caco-2 cells), including sample collection, pretreatment, quantitative detection, and data modeling analysis, to clarify core PK parameters (bioavailability, half-life, clearance rate, volume of distribution, etc.), reveal the drug’s disposition rules in organisms, and provide critical data support for candidate drug screening and optimization, dosage form design, toxicology study matching, and rational transition to clinical trials, helping drug R&D institutions reduce R&D risks, improve R&D efficiency and ensure the scientificity of subsequent research layouts.

The North American market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Preclinical Pharmacokinetics Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Preclinical Pharmacokinetics Services in Innovative Small Molecule Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Preclinical Pharmacokinetics Services include Porsolt, Altasciences, Biocytogen, Charles River Laboratories, WuXi AppTec, PyschoGenics, Evotec (Cyprotex), QPS, Aurigene Pharmaceutical Services, Frontage Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Preclinical Pharmacokinetics Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Preclinical Pharmacokinetics Services. The Preclinical Pharmacokinetics Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Preclinical Pharmacokinetics Services market comprehensively. Regional market sizes by Type, by Application, by Experimental System, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Preclinical Pharmacokinetics Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Preclinical Pharmacokinetics Services Market Report

Report Metric	Details
Report Name	Preclinical Pharmacokinetics Services Market
Accounted market size in 2025	US$ 782 million
Forecasted market size in 2032	US$ 1123 million
CAGR	5.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	LC-MS/MS-Based Preclinical Pharmacokinetics Service Immunoassay-Based Preclinical Pharmacokinetics Service Others
Segment by Experimental System	In Vitro Preclinical Pharmacokinetics Service In Vivo Preclinical Pharmacokinetics Service
Segment by Application	Innovative Small Molecule Drugs Biopharmaceuticals Traditional Chinese Medicine & Natural Products Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Porsolt, Altasciences, Biocytogen, Charles River Laboratories, WuXi AppTec, PyschoGenics, Evotec (Cyprotex), QPS, Aurigene Pharmaceutical Services, Frontage Laboratories, Dalriada, Sygnature Discovery, Admescope, Imavita, IQVIA Laboratories, Pharmaron
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Experimental System, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Preclinical Pharmacokinetics Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Preclinical Pharmacokinetics Services Market growing?

Ans: The Preclinical Pharmacokinetics Services Market witnessing a CAGR of 5.3% during the forecast period 2026-2032.

What is the Preclinical Pharmacokinetics Services Market size in 2032?

Ans: The Preclinical Pharmacokinetics Services Market size in 2032 will be US$ 1123 million.

Who are the main players in the Preclinical Pharmacokinetics Services Market report?

Ans: The main players in the Preclinical Pharmacokinetics Services Market are Porsolt, Altasciences, Biocytogen, Charles River Laboratories, WuXi AppTec, PyschoGenics, Evotec (Cyprotex), QPS, Aurigene Pharmaceutical Services, Frontage Laboratories, Dalriada, Sygnature Discovery, Admescope, Imavita, IQVIA Laboratories, Pharmaron

What are the Application segmentation covered in the Preclinical Pharmacokinetics Services Market report?

Ans: The Applications covered in the Preclinical Pharmacokinetics Services Market report are Innovative Small Molecule Drugs, Biopharmaceuticals, Traditional Chinese Medicine & Natural Products, Others

What are the Type segmentation covered in the Preclinical Pharmacokinetics Services Market report?

Ans: The Types covered in the Preclinical Pharmacokinetics Services Market report are LC-MS/MS-Based Preclinical Pharmacokinetics Service, Immunoassay-Based Preclinical Pharmacokinetics Service, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 LC-MS/MS-Based Preclinical Pharmacokinetics Service

1.2.3 Immunoassay-Based Preclinical Pharmacokinetics Service

1.2.4 Others

1.3 Market by Experimental System

1.3.1 Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Experimental System: 2021 vs 2025 vs 2032

1.3.2 In Vitro Preclinical Pharmacokinetics Service

1.3.3 In Vivo Preclinical Pharmacokinetics Service

1.4 Market by Application

1.4.1 Global Preclinical Pharmacokinetics Services Market Growth by Application: 2021 vs 2025 vs 2032

1.4.2 Innovative Small Molecule Drugs

1.4.3 Biopharmaceuticals

1.4.4 Traditional Chinese Medicine & Natural Products

1.4.5 Others

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Preclinical Pharmacokinetics Services Market Perspective (2021–2032)

2.2 Global Preclinical Pharmacokinetics Services Growth Trends by Region

2.2.1 Global Preclinical Pharmacokinetics Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Preclinical Pharmacokinetics Services Historic Market Size by Region (2021–2026)

2.2.3 Preclinical Pharmacokinetics Services Forecasted Market Size by Region (2027–2032)

2.3 Preclinical Pharmacokinetics Services Market Dynamics

2.3.1 Preclinical Pharmacokinetics Services Industry Trends

2.3.2 Preclinical Pharmacokinetics Services Market Drivers

2.3.3 Preclinical Pharmacokinetics Services Market Challenges

2.3.4 Preclinical Pharmacokinetics Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Preclinical Pharmacokinetics Services Players by Revenue

3.1.1 Global Top Preclinical Pharmacokinetics Services Players by Revenue (2021–2026)

3.1.2 Global Preclinical Pharmacokinetics Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Preclinical Pharmacokinetics Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Preclinical Pharmacokinetics Services Revenue

3.4 Global Preclinical Pharmacokinetics Services Market Concentration Ratio

3.4.1 Global Preclinical Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Preclinical Pharmacokinetics Services Revenue in 2025

3.5 Global Key Players of Preclinical Pharmacokinetics Services Head Offices and Areas Served

3.6 Global Key Players of Preclinical Pharmacokinetics Services, Products and Applications

3.7 Global Key Players of Preclinical Pharmacokinetics Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Preclinical Pharmacokinetics Services Breakdown Data by Type

4.1 Global Preclinical Pharmacokinetics Services Historic Market Size by Type (2021–2026)

4.2 Global Preclinical Pharmacokinetics Services Forecasted Market Size by Type (2027–2032)

5 Preclinical Pharmacokinetics Services Breakdown Data by Application

5.1 Global Preclinical Pharmacokinetics Services Historic Market Size by Application (2021–2026)

5.2 Global Preclinical Pharmacokinetics Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Preclinical Pharmacokinetics Services Market Size (2021–2032)

6.2 North America Preclinical Pharmacokinetics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Preclinical Pharmacokinetics Services Market Size by Country (2021–2026)

6.4 North America Preclinical Pharmacokinetics Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Preclinical Pharmacokinetics Services Market Size (2021–2032)

7.2 Europe Preclinical Pharmacokinetics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Preclinical Pharmacokinetics Services Market Size by Country (2021–2026)

7.4 Europe Preclinical Pharmacokinetics Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Preclinical Pharmacokinetics Services Market Size (2021–2032)

8.2 Asia-Pacific Preclinical Pharmacokinetics Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Preclinical Pharmacokinetics Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Preclinical Pharmacokinetics Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Preclinical Pharmacokinetics Services Market Size (2021–2032)

9.2 Latin America Preclinical Pharmacokinetics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Preclinical Pharmacokinetics Services Market Size by Country (2021–2026)

9.4 Latin America Preclinical Pharmacokinetics Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Preclinical Pharmacokinetics Services Market Size (2021–2032)

10.2 Middle East & Africa Preclinical Pharmacokinetics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Porsolt

11.1.1 Porsolt Company Details

11.1.2 Porsolt Business Overview

11.1.3 Porsolt Preclinical Pharmacokinetics Services Introduction

11.1.4 Porsolt Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.1.5 Porsolt Recent Development

11.2 Altasciences

11.2.1 Altasciences Company Details

11.2.2 Altasciences Business Overview

11.2.3 Altasciences Preclinical Pharmacokinetics Services Introduction

11.2.4 Altasciences Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.2.5 Altasciences Recent Development

11.3 Biocytogen

11.3.1 Biocytogen Company Details

11.3.2 Biocytogen Business Overview

11.3.3 Biocytogen Preclinical Pharmacokinetics Services Introduction

11.3.4 Biocytogen Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.3.5 Biocytogen Recent Development

11.4 Charles River Laboratories

11.4.1 Charles River Laboratories Company Details

11.4.2 Charles River Laboratories Business Overview

11.4.3 Charles River Laboratories Preclinical Pharmacokinetics Services Introduction

11.4.4 Charles River Laboratories Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.4.5 Charles River Laboratories Recent Development

11.5 WuXi AppTec

11.5.1 WuXi AppTec Company Details

11.5.2 WuXi AppTec Business Overview

11.5.3 WuXi AppTec Preclinical Pharmacokinetics Services Introduction

11.5.4 WuXi AppTec Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.5.5 WuXi AppTec Recent Development

11.6 PyschoGenics

11.6.1 PyschoGenics Company Details

11.6.2 PyschoGenics Business Overview

11.6.3 PyschoGenics Preclinical Pharmacokinetics Services Introduction

11.6.4 PyschoGenics Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.6.5 PyschoGenics Recent Development

11.7 Evotec (Cyprotex)

11.7.1 Evotec (Cyprotex) Company Details

11.7.2 Evotec (Cyprotex) Business Overview

11.7.3 Evotec (Cyprotex) Preclinical Pharmacokinetics Services Introduction

11.7.4 Evotec (Cyprotex) Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.7.5 Evotec (Cyprotex) Recent Development

11.8 QPS

11.8.1 QPS Company Details

11.8.2 QPS Business Overview

11.8.3 QPS Preclinical Pharmacokinetics Services Introduction

11.8.4 QPS Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.8.5 QPS Recent Development

11.9 Aurigene Pharmaceutical Services

11.9.1 Aurigene Pharmaceutical Services Company Details

11.9.2 Aurigene Pharmaceutical Services Business Overview

11.9.3 Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Introduction

11.9.4 Aurigene Pharmaceutical Services Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.9.5 Aurigene Pharmaceutical Services Recent Development

11.10 Frontage Laboratories

11.10.1 Frontage Laboratories Company Details

11.10.2 Frontage Laboratories Business Overview

11.10.3 Frontage Laboratories Preclinical Pharmacokinetics Services Introduction

11.10.4 Frontage Laboratories Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.10.5 Frontage Laboratories Recent Development

11.11 Dalriada

11.11.1 Dalriada Company Details

11.11.2 Dalriada Business Overview

11.11.3 Dalriada Preclinical Pharmacokinetics Services Introduction

11.11.4 Dalriada Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.11.5 Dalriada Recent Development

11.12 Sygnature Discovery

11.12.1 Sygnature Discovery Company Details

11.12.2 Sygnature Discovery Business Overview

11.12.3 Sygnature Discovery Preclinical Pharmacokinetics Services Introduction

11.12.4 Sygnature Discovery Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.12.5 Sygnature Discovery Recent Development

11.13 Admescope

11.13.1 Admescope Company Details

11.13.2 Admescope Business Overview

11.13.3 Admescope Preclinical Pharmacokinetics Services Introduction

11.13.4 Admescope Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.13.5 Admescope Recent Development

11.14 Imavita

11.14.1 Imavita Company Details

11.14.2 Imavita Business Overview

11.14.3 Imavita Preclinical Pharmacokinetics Services Introduction

11.14.4 Imavita Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.14.5 Imavita Recent Development

11.15 IQVIA Laboratories

11.15.1 IQVIA Laboratories Company Details

11.15.2 IQVIA Laboratories Business Overview

11.15.3 IQVIA Laboratories Preclinical Pharmacokinetics Services Introduction

11.15.4 IQVIA Laboratories Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.15.5 IQVIA Laboratories Recent Development

11.16 Pharmaron

11.16.1 Pharmaron Company Details

11.16.2 Pharmaron Business Overview

11.16.3 Pharmaron Preclinical Pharmacokinetics Services Introduction

11.16.4 Pharmaron Revenue in Preclinical Pharmacokinetics Services Business (2021–2026)

11.16.5 Pharmaron Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Porsolt

ALTASCIENCES

BIOCYTOGEN

Charles River Laboratories

WuXi AppTec

QPS

Aurigene Pharmaceutical Services

Frontage Laboratories

List of Tables

Table 1. Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of LC-MS/MS-Based Preclinical Pharmacokinetics Service

Table 3. Key Players of Immunoassay-Based Preclinical Pharmacokinetics Service

Table 4. Key Players of Others

Table 5. Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Experimental System (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of In Vitro Preclinical Pharmacokinetics Service

Table 7. Key Players of In Vivo Preclinical Pharmacokinetics Service

Table 8. Global Preclinical Pharmacokinetics Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Preclinical Pharmacokinetics Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Preclinical Pharmacokinetics Services Market Size by Region (US$ Million), 2021–2026

Table 11. Global Preclinical Pharmacokinetics Services Market Share by Region (2021–2026)

Table 12. Global Preclinical Pharmacokinetics Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 13. Global Preclinical Pharmacokinetics Services Market Share by Region (2027–2032)

Table 14. Preclinical Pharmacokinetics Services Market Trends

Table 15. Preclinical Pharmacokinetics Services Market Drivers

Table 16. Preclinical Pharmacokinetics Services Market Challenges

Table 17. Preclinical Pharmacokinetics Services Market Restraints

Table 18. Global Preclinical Pharmacokinetics Services Revenue by Players (US$ Million), 2021–2026

Table 19. Global Preclinical Pharmacokinetics Services Market Share by Players (2021–2026)

Table 20. Global Top Preclinical Pharmacokinetics Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Preclinical Pharmacokinetics Services Revenue, 2025

Table 21. Ranking of Global Top Preclinical Pharmacokinetics Services Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Preclinical Pharmacokinetics Services Revenue (CR5 and HHI), 2021–2026

Table 23. Global Key Players of Preclinical Pharmacokinetics Services, Headquarters and Area Served

Table 24. Global Key Players of Preclinical Pharmacokinetics Services, Products and Applications

Table 25. Global Key Players of Preclinical Pharmacokinetics Services, Date of General Availability (GA)

Table 26. Mergers and Acquisitions, Expansion Plans

Table 27. Global Preclinical Pharmacokinetics Services Market Size by Type (US$ Million), 2021–2026

Table 28. Global Preclinical Pharmacokinetics Services Revenue Market Share by Type (2021–2026)

Table 29. Global Preclinical Pharmacokinetics Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 30. Global Preclinical Pharmacokinetics Services Revenue Market Share by Type (2027–2032)

Table 31. Global Preclinical Pharmacokinetics Services Market Size by Application (US$ Million), 2021–2026

Table 32. Global Preclinical Pharmacokinetics Services Revenue Market Share by Application (2021–2026)

Table 33. Global Preclinical Pharmacokinetics Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 34. Global Preclinical Pharmacokinetics Services Revenue Market Share by Application (2027–2032)

Table 35. North America Preclinical Pharmacokinetics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. North America Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2021–2026

Table 37. North America Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2027–2032

Table 38. Europe Preclinical Pharmacokinetics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 39. Europe Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2021–2026

Table 40. Europe Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2027–2032

Table 41. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 42. Asia-Pacific Preclinical Pharmacokinetics Services Market Size by Region (US$ Million), 2021–2026

Table 43. Asia-Pacific Preclinical Pharmacokinetics Services Market Size by Region (US$ Million), 2027–2032

Table 44. Latin America Preclinical Pharmacokinetics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Latin America Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2021–2026

Table 46. Latin America Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2027–2032

Table 47. Middle East & Africa Preclinical Pharmacokinetics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2021–2026

Table 49. Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (US$ Million), 2027–2032

Table 50. Porsolt Company Details

Table 51. Porsolt Business Overview

Table 52. Porsolt Preclinical Pharmacokinetics Services Product

Table 53. Porsolt Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 54. Porsolt Recent Development

Table 55. Altasciences Company Details

Table 56. Altasciences Business Overview

Table 57. Altasciences Preclinical Pharmacokinetics Services Product

Table 58. Altasciences Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 59. Altasciences Recent Development

Table 60. Biocytogen Company Details

Table 61. Biocytogen Business Overview

Table 62. Biocytogen Preclinical Pharmacokinetics Services Product

Table 63. Biocytogen Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 64. Biocytogen Recent Development

Table 65. Charles River Laboratories Company Details

Table 66. Charles River Laboratories Business Overview

Table 67. Charles River Laboratories Preclinical Pharmacokinetics Services Product

Table 68. Charles River Laboratories Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 69. Charles River Laboratories Recent Development

Table 70. WuXi AppTec Company Details

Table 71. WuXi AppTec Business Overview

Table 72. WuXi AppTec Preclinical Pharmacokinetics Services Product

Table 73. WuXi AppTec Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 74. WuXi AppTec Recent Development

Table 75. PyschoGenics Company Details

Table 76. PyschoGenics Business Overview

Table 77. PyschoGenics Preclinical Pharmacokinetics Services Product

Table 78. PyschoGenics Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 79. PyschoGenics Recent Development

Table 80. Evotec (Cyprotex) Company Details

Table 81. Evotec (Cyprotex) Business Overview

Table 82. Evotec (Cyprotex) Preclinical Pharmacokinetics Services Product

Table 83. Evotec (Cyprotex) Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 84. Evotec (Cyprotex) Recent Development

Table 85. QPS Company Details

Table 86. QPS Business Overview

Table 87. QPS Preclinical Pharmacokinetics Services Product

Table 88. QPS Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 89. QPS Recent Development

Table 90. Aurigene Pharmaceutical Services Company Details

Table 91. Aurigene Pharmaceutical Services Business Overview

Table 92. Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Product

Table 93. Aurigene Pharmaceutical Services Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 94. Aurigene Pharmaceutical Services Recent Development

Table 95. Frontage Laboratories Company Details

Table 96. Frontage Laboratories Business Overview

Table 97. Frontage Laboratories Preclinical Pharmacokinetics Services Product

Table 98. Frontage Laboratories Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 99. Frontage Laboratories Recent Development

Table 100. Dalriada Company Details

Table 101. Dalriada Business Overview

Table 102. Dalriada Preclinical Pharmacokinetics Services Product

Table 103. Dalriada Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 104. Dalriada Recent Development

Table 105. Sygnature Discovery Company Details

Table 106. Sygnature Discovery Business Overview

Table 107. Sygnature Discovery Preclinical Pharmacokinetics Services Product

Table 108. Sygnature Discovery Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 109. Sygnature Discovery Recent Development

Table 110. Admescope Company Details

Table 111. Admescope Business Overview

Table 112. Admescope Preclinical Pharmacokinetics Services Product

Table 113. Admescope Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 114. Admescope Recent Development

Table 115. Imavita Company Details

Table 116. Imavita Business Overview

Table 117. Imavita Preclinical Pharmacokinetics Services Product

Table 118. Imavita Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 119. Imavita Recent Development

Table 120. IQVIA Laboratories Company Details

Table 121. IQVIA Laboratories Business Overview

Table 122. IQVIA Laboratories Preclinical Pharmacokinetics Services Product

Table 123. IQVIA Laboratories Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 124. IQVIA Laboratories Recent Development

Table 125. Pharmaron Company Details

Table 126. Pharmaron Business Overview

Table 127. Pharmaron Preclinical Pharmacokinetics Services Product

Table 128. Pharmaron Revenue in Preclinical Pharmacokinetics Services Business (US$ Million), 2021–2026

Table 129. Pharmaron Recent Development

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Authors List of This Report

List of Figures

Figure 1. Preclinical Pharmacokinetics Services Picture

Figure 2. Global Preclinical Pharmacokinetics Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Preclinical Pharmacokinetics Services Market Share by Type: 2025 vs 2032

Figure 4. LC-MS/MS-Based Preclinical Pharmacokinetics Service Features

Figure 5. Immunoassay-Based Preclinical Pharmacokinetics Service Features

Figure 6. Others Features

Figure 7. Global Preclinical Pharmacokinetics Services Market Size Comparison by Experimental System (US$ Million), 2021–2032

Figure 8. In Vitro Preclinical Pharmacokinetics Service Features

Figure 9. In Vivo Preclinical Pharmacokinetics Service Features

Figure 10. Global Preclinical Pharmacokinetics Services Market Size by Application (US$ Million), 2021–2032

Figure 11. Global Preclinical Pharmacokinetics Services Market Share by Application: 2025 vs 2032

Figure 12. Innovative Small Molecule Drugs Case Studies

Figure 13. Biopharmaceuticals Case Studies

Figure 14. Traditional Chinese Medicine & Natural Products Case Studies

Figure 15. Others Case Studies

Figure 16. Preclinical Pharmacokinetics Services Report Years Considered

Figure 17. Global Preclinical Pharmacokinetics Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 18. Global Preclinical Pharmacokinetics Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Preclinical Pharmacokinetics Services Market Share by Region: 2025 vs 2032

Figure 20. Global Preclinical Pharmacokinetics Services Market Share by Players in 2025

Figure 21. Global Preclinical Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Preclinical Pharmacokinetics Services Revenue in 2025

Figure 23. North America Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. North America Preclinical Pharmacokinetics Services Market Share by Country (2021–2032)

Figure 25. United States Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Canada Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Preclinical Pharmacokinetics Services Market Share by Country (2021–2032)

Figure 29. Germany Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. France Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. U.K. Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Italy Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Russia Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Ireland Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Preclinical Pharmacokinetics Services Market Share by Region (2021–2032)

Figure 37. China Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Japan Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. South Korea Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Southeast Asia Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. India Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Australia & New Zealand Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Preclinical Pharmacokinetics Services Market Share by Country (2021–2032)

Figure 45. Mexico Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Brazil Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Country (2021–2032)

Figure 49. Israel Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Saudi Arabia Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. UAE Preclinical Pharmacokinetics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Porsolt Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 53. Altasciences Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 54. Biocytogen Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 55. Charles River Laboratories Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 56. WuXi AppTec Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 57. PyschoGenics Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 58. Evotec (Cyprotex) Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 59. QPS Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 60. Aurigene Pharmaceutical Services Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 61. Frontage Laboratories Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 62. Dalriada Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 63. Sygnature Discovery Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 64. Admescope Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 65. Imavita Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 66. IQVIA Laboratories Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 67. Pharmaron Revenue Growth Rate in Preclinical Pharmacokinetics Services Business (2021–2026)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions